At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD
In Brief
A Phase 2 clinical trial evaluating Glycopyrrolate (85 μg), Glycopyrrolate (42.5 μg), and 2 other interventions for Chronic Obstructive Pulmonary Disease. Completed, enrolled 46 participants across 7 sites.
Detailed Summary
This study is a randomized, double-blind, placebo-controlled complete block cross-over study designed to assess the efficacy, safety, and pharmacokinetics of 3 dose levels of glycopyrrolate inhalation solution delivered twice daily via standard jet nebulizer over three 1-week active treatment periods and one 1-week placebo period in subjects with chronic obstructive pulmonary disease (COPD).
Study Details
Timeline
Interventions
Administered by a standard jet nebulizer, twice daily for 7 consecutive days
Administered by a standard jet nebulizer, twice daily for 7 consecutive days
Administered by a standard jet nebulizer, twice daily for 7 consecutive days
Administered by a standard jet nebulizer, twice daily for 7 consecutive days